This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Medimmune Limited. Active years: 2020-2024.
Company Filing History:
Years Active: 2020-2024
Title: The Innovative Contributions of Matthew Gardener
Introduction
Matthew Gardener is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of neurodegenerative disease research. With a total of 2 patents to his name, Gardener is recognized for his innovative approaches to medical treatments.
Latest Patents
Gardener's latest patents include a method for treating a neurodegenerative disease by administering an anti-cellular prion protein (PrP) antibody. This patent provides antibodies and antigen-binding fragments capable of binding PrP. Additionally, he has developed another patent focused on anti-PrP antibodies and their uses, which also includes methods for making and utilizing these antibodies and fragments.
Career Highlights
Matthew Gardener is currently employed at Medimmune Limited, where he continues to advance his research and development efforts. His work is pivotal in the ongoing fight against neurodegenerative diseases, showcasing his commitment to improving patient outcomes.
Collaborations
Gardener collaborates with talented professionals in his field, including Jayne Hammersley and Maria Groves. Their combined expertise enhances the innovative environment at Medimmune Limited.
Conclusion
Matthew Gardener's contributions to the field of neurodegenerative disease research are commendable. His patents reflect a dedication to advancing medical science and improving therapeutic options for patients.